Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration, Dry”

280 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 280 results

Not applicableLooking for participantsNCT03921931
What this trial is testing

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Who this might be right for
Macular Degeneration, DryPrimary Open-angle Glaucoma
Medical University of Vienna 35
Not applicableLooking for participantsNCT06375239
What this trial is testing

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Who this might be right for
Retinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more
Ray Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07215234
What this trial is testing

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
Sanofi 104
Testing effectiveness (Phase 2)Ended earlyNCT05019521
What this trial is testing

Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Alexion Pharmaceuticals, Inc. 365
Large-scale testing (Phase 3)Active Not RecruitingNCT06229665
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 75
Not applicableLooking for participantsNCT04129021
What this trial is testing

High Resolution, High-speed Multimodal Ophthalmic Imaging

Who this might be right for
Retinitis PigmentosaMaculopathy, Age RelatedMacular Dystrophy+12 more
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 1,200
Early research (Phase 1)Study completedNCT01922128
What this trial is testing

Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

Who this might be right for
Nonexudative Age-related Macular Degeneration
MacuCLEAR, Inc. 20
Early research (Phase 1)Study completedNCT06006585
What this trial is testing

Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 20
Not applicableEnded earlyNCT05200624
What this trial is testing

Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study

Who this might be right for
Age-Related Macular Degeneration
Center for Eye Research Australia 15
Testing effectiveness (Phase 2)Study completedNCT00346060
What this trial is testing

Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.

Who this might be right for
Dry Age Related Macular Degeneration.
Radtke, Norman D., M.D. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05170048
What this trial is testing

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD

Who this might be right for
Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
Evergreen Therapeutics, Inc. 90
Not applicableStudy completedNCT02332343
What this trial is testing

Sparing of the Fovea in Geographic Atrophy Progression

Who this might be right for
AtrophyGeographic AtrophyAge-related Macular Degeneration+1 more
University Hospital, Bonn 26
Testing effectiveness (Phase 2)Study completedNCT00306488
What this trial is testing

OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular DegenerationAMD
National Institutes of Health Clinical Center (CC) 11
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Not applicableUnknownNCT02372916
What this trial is testing

Geographic Atrophy and Intravitreal Ranibizumab Injections

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
University Health Network, Toronto 90
Testing effectiveness (Phase 2)Study completedNCT02564978
What this trial is testing

Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 37
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Not applicableLooking for participantsNCT05706896
What this trial is testing

Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma

Who this might be right for
Dry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Not applicableLooking for participantsNCT06046118
What this trial is testing

Photobiomodulation in Dry Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 180
Early research (Phase 1)Study completedNCT00950638
What this trial is testing

ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Who this might be right for
Dry Age-Related Macular Degeneration
Ophthotech Corporation 47
Load More Results